Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
Identifieur interne : 001812 ( PubMed/Checkpoint ); précédent : 001811; suivant : 001813Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
Auteurs : B. Nandha [Inde] ; K. Krishnamoorthy ; P. JambulingamSource :
- Health education research [ 1465-3648 ] ; 2013.
Descripteurs français
- KwdFr :
- Agents de santé communautaire (organisation et administration), Albendazole (administration et posologie), Albendazole (ressources et distribution), Albendazole (usage thérapeutique), Animaux, Calendrier d'administration des médicaments, Diéthylcarbamazine (administration et posologie), Diéthylcarbamazine (usage thérapeutique), Filaricides (administration et posologie), Filaricides (ressources et distribution), Filaricides (usage thérapeutique), Filariose lymphatique (), Filariose lymphatique (traitement médicamenteux), Filariose lymphatique (épidémiologie), Humains, Inde (épidémiologie), Ivermectine (administration et posologie), Ivermectine (ressources et distribution), Ivermectine (usage thérapeutique), Maladies endémiques (), Microfilaria (), Microfilaria (croissance et développement), Observance du traitement médicamenteux (), Observance du traitement médicamenteux (psychologie), Participation communautaire, Politique de santé, Programmes nationaux de santé (organisation et administration), Santé mondiale, Services de médecine préventive (main d’œuvre), Services de médecine préventive (organisation et administration), Services de santé communautaires (main d’œuvre), Services de santé communautaires (organisation et administration), Visites à domicile, Éradication de maladie (), Éradication de maladie (normes).
- MESH :
- administration et posologie : Albendazole, Diéthylcarbamazine, Filaricides, Ivermectine.
- croissance et développement : Microfilaria.
- main d’œuvre : Services de médecine préventive, Services de santé communautaires.
- normes : Éradication de maladie.
- organisation et administration : Agents de santé communautaire, Programmes nationaux de santé, Services de médecine préventive, Services de santé communautaires.
- psychologie : Observance du traitement médicamenteux.
- ressources et distribution : Albendazole, Filaricides, Ivermectine.
- traitement médicamenteux : Filariose lymphatique.
- usage thérapeutique : Albendazole, Diéthylcarbamazine, Filaricides, Ivermectine.
- épidémiologie : Filariose lymphatique, Inde.
- Animaux, Calendrier d'administration des médicaments, Filariose lymphatique, Humains, Maladies endémiques, Microfilaria, Observance du traitement médicamenteux, Participation communautaire, Politique de santé, Santé mondiale, Visites à domicile, Éradication de maladie.
English descriptors
- KwdEn :
- Albendazole (administration & dosage), Albendazole (supply & distribution), Albendazole (therapeutic use), Animals, Community Health Services (manpower), Community Health Services (organization & administration), Community Health Workers (organization & administration), Community Participation, Diethylcarbamazine (administration & dosage), Diethylcarbamazine (therapeutic use), Disease Eradication (methods), Disease Eradication (standards), Drug Administration Schedule, Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (epidemiology), Elephantiasis, Filarial (prevention & control), Endemic Diseases (prevention & control), Filaricides (administration & dosage), Filaricides (supply & distribution), Filaricides (therapeutic use), Global Health, Health Policy, House Calls, Humans, India (epidemiology), Ivermectin (administration & dosage), Ivermectin (supply & distribution), Ivermectin (therapeutic use), Medication Adherence (psychology), Medication Adherence (statistics & numerical data), Microfilariae (drug effects), Microfilariae (growth & development), National Health Programs (organization & administration), Preventive Health Services (manpower), Preventive Health Services (organization & administration).
- MESH :
- chemical , administration & dosage : Albendazole, Diethylcarbamazine, Filaricides, Ivermectin.
- chemical , supply & distribution : Albendazole, Filaricides, Ivermectin.
- chemical , therapeutic use : Albendazole, Diethylcarbamazine, Filaricides, Ivermectin.
- drug effects : Microfilariae.
- drug therapy : Elephantiasis, Filarial.
- epidemiology : Elephantiasis, Filarial, India.
- growth & development : Microfilariae.
- manpower : Community Health Services, Preventive Health Services.
- methods : Disease Eradication.
- organization & administration : Community Health Services, Community Health Workers, National Health Programs, Preventive Health Services.
- prevention & control : Elephantiasis, Filarial, Endemic Diseases.
- psychology : Medication Adherence.
- standards : Disease Eradication.
- statistics & numerical data : Medication Adherence.
- Animals, Community Participation, Drug Administration Schedule, Global Health, Health Policy, House Calls, Humans.
Abstract
India is a signatory to World Health Assembly resolution for elimination of lymphatic filariasis (LF) and National Health Policy has set the goal of LF elimination by 2015. Annual mass drug administration (MDA) is ongoing in endemic districts since 1996-97. Compliance rate is a crucial factor in achieving elimination and was assessed in three districts of Tamil Nadu for 10th and 11th treatment rounds (TRs). An in-depth study assessed the impact of social mobilization by drug distributors (DDs) in two areas from each of the three districts. Overall coverage and compliance for assessed TRs were 76.3 and 67.7% which is below the optimum level to achieve LF elimination. Modifiable determinants continue to be the reason for non-consumption even in the 11th TR and 20.8% were systematic non-compliers. In 76.4% of the cases, DDs failed to adhere to three mandatory visits as per the guidelines. Number of visits by DDs in relation to low and high MDA coverage areas showed a significant relationship (P ≤ 0.000). MDA is limited to drug distribution alone and efforts by DDs in preparing the community were inadequate. Probable means to meet the challenges in preparation of the community is discussed.
DOI: 10.1093/her/cyt042
PubMed: 23503571
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:23503571Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.</title><author><name sortKey="Nandha, B" sort="Nandha, B" uniqKey="Nandha B" first="B" last="Nandha">B. Nandha</name><affiliation wicri:level="1"><nlm:affiliation>Vector Control Research Centre (Indian Council of Medical Research), Medical Complex, Indira Nagar Pondicherry 605 006, India. nandabasker@gmail.com</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Vector Control Research Centre (Indian Council of Medical Research), Medical Complex, Indira Nagar Pondicherry 605 006</wicri:regionArea><wicri:noRegion>Indira Nagar Pondicherry 605 006</wicri:noRegion></affiliation></author><author><name sortKey="Krishnamoorthy, K" sort="Krishnamoorthy, K" uniqKey="Krishnamoorthy K" first="K" last="Krishnamoorthy">K. Krishnamoorthy</name></author><author><name sortKey="Jambulingam, P" sort="Jambulingam, P" uniqKey="Jambulingam P" first="P" last="Jambulingam">P. Jambulingam</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23503571</idno><idno type="pmid">23503571</idno><idno type="doi">10.1093/her/cyt042</idno><idno type="wicri:Area/PubMed/Corpus">001C50</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001C50</idno><idno type="wicri:Area/PubMed/Curation">001C50</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001C50</idno><idno type="wicri:Area/PubMed/Checkpoint">001C50</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001C50</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.</title><author><name sortKey="Nandha, B" sort="Nandha, B" uniqKey="Nandha B" first="B" last="Nandha">B. Nandha</name><affiliation wicri:level="1"><nlm:affiliation>Vector Control Research Centre (Indian Council of Medical Research), Medical Complex, Indira Nagar Pondicherry 605 006, India. nandabasker@gmail.com</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Vector Control Research Centre (Indian Council of Medical Research), Medical Complex, Indira Nagar Pondicherry 605 006</wicri:regionArea><wicri:noRegion>Indira Nagar Pondicherry 605 006</wicri:noRegion></affiliation></author><author><name sortKey="Krishnamoorthy, K" sort="Krishnamoorthy, K" uniqKey="Krishnamoorthy K" first="K" last="Krishnamoorthy">K. Krishnamoorthy</name></author><author><name sortKey="Jambulingam, P" sort="Jambulingam, P" uniqKey="Jambulingam P" first="P" last="Jambulingam">P. Jambulingam</name></author></analytic><series><title level="j">Health education research</title><idno type="eISSN">1465-3648</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Albendazole (administration & dosage)</term><term>Albendazole (supply & distribution)</term><term>Albendazole (therapeutic use)</term><term>Animals</term><term>Community Health Services (manpower)</term><term>Community Health Services (organization & administration)</term><term>Community Health Workers (organization & administration)</term><term>Community Participation</term><term>Diethylcarbamazine (administration & dosage)</term><term>Diethylcarbamazine (therapeutic use)</term><term>Disease Eradication (methods)</term><term>Disease Eradication (standards)</term><term>Drug Administration Schedule</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Elephantiasis, Filarial (epidemiology)</term><term>Elephantiasis, Filarial (prevention & control)</term><term>Endemic Diseases (prevention & control)</term><term>Filaricides (administration & dosage)</term><term>Filaricides (supply & distribution)</term><term>Filaricides (therapeutic use)</term><term>Global Health</term><term>Health Policy</term><term>House Calls</term><term>Humans</term><term>India (epidemiology)</term><term>Ivermectin (administration & dosage)</term><term>Ivermectin (supply & distribution)</term><term>Ivermectin (therapeutic use)</term><term>Medication Adherence (psychology)</term><term>Medication Adherence (statistics & numerical data)</term><term>Microfilariae (drug effects)</term><term>Microfilariae (growth & development)</term><term>National Health Programs (organization & administration)</term><term>Preventive Health Services (manpower)</term><term>Preventive Health Services (organization & administration)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Agents de santé communautaire (organisation et administration)</term><term>Albendazole (administration et posologie)</term><term>Albendazole (ressources et distribution)</term><term>Albendazole (usage thérapeutique)</term><term>Animaux</term><term>Calendrier d'administration des médicaments</term><term>Diéthylcarbamazine (administration et posologie)</term><term>Diéthylcarbamazine (usage thérapeutique)</term><term>Filaricides (administration et posologie)</term><term>Filaricides (ressources et distribution)</term><term>Filaricides (usage thérapeutique)</term><term>Filariose lymphatique ()</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Filariose lymphatique (épidémiologie)</term><term>Humains</term><term>Inde (épidémiologie)</term><term>Ivermectine (administration et posologie)</term><term>Ivermectine (ressources et distribution)</term><term>Ivermectine (usage thérapeutique)</term><term>Maladies endémiques ()</term><term>Microfilaria ()</term><term>Microfilaria (croissance et développement)</term><term>Observance du traitement médicamenteux ()</term><term>Observance du traitement médicamenteux (psychologie)</term><term>Participation communautaire</term><term>Politique de santé</term><term>Programmes nationaux de santé (organisation et administration)</term><term>Santé mondiale</term><term>Services de médecine préventive (main d’œuvre)</term><term>Services de médecine préventive (organisation et administration)</term><term>Services de santé communautaires (main d’œuvre)</term><term>Services de santé communautaires (organisation et administration)</term><term>Visites à domicile</term><term>Éradication de maladie ()</term><term>Éradication de maladie (normes)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Albendazole</term><term>Diethylcarbamazine</term><term>Filaricides</term><term>Ivermectin</term></keywords><keywords scheme="MESH" type="chemical" qualifier="supply & distribution" xml:lang="en"><term>Albendazole</term><term>Filaricides</term><term>Ivermectin</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Albendazole</term><term>Diethylcarbamazine</term><term>Filaricides</term><term>Ivermectin</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Albendazole</term><term>Diéthylcarbamazine</term><term>Filaricides</term><term>Ivermectine</term></keywords><keywords scheme="MESH" qualifier="croissance et développement" xml:lang="fr"><term>Microfilaria</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Microfilariae</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term><term>India</term></keywords><keywords scheme="MESH" qualifier="growth & development" xml:lang="en"><term>Microfilariae</term></keywords><keywords scheme="MESH" qualifier="main d’œuvre" xml:lang="fr"><term>Services de médecine préventive</term><term>Services de santé communautaires</term></keywords><keywords scheme="MESH" qualifier="manpower" xml:lang="en"><term>Community Health Services</term><term>Preventive Health Services</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Disease Eradication</term></keywords><keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Éradication de maladie</term></keywords><keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr"><term>Agents de santé communautaire</term><term>Programmes nationaux de santé</term><term>Services de médecine préventive</term><term>Services de santé communautaires</term></keywords><keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Community Health Services</term><term>Community Health Workers</term><term>National Health Programs</term><term>Preventive Health Services</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term><term>Endemic Diseases</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Observance du traitement médicamenteux</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Medication Adherence</term></keywords><keywords scheme="MESH" qualifier="ressources et distribution" xml:lang="fr"><term>Albendazole</term><term>Filaricides</term><term>Ivermectine</term></keywords><keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Disease Eradication</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Medication Adherence</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Albendazole</term><term>Diéthylcarbamazine</term><term>Filaricides</term><term>Ivermectine</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term><term>Inde</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Community Participation</term><term>Drug Administration Schedule</term><term>Global Health</term><term>Health Policy</term><term>House Calls</term><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Calendrier d'administration des médicaments</term><term>Filariose lymphatique</term><term>Humains</term><term>Maladies endémiques</term><term>Microfilaria</term><term>Observance du traitement médicamenteux</term><term>Participation communautaire</term><term>Politique de santé</term><term>Santé mondiale</term><term>Visites à domicile</term><term>Éradication de maladie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">India is a signatory to World Health Assembly resolution for elimination of lymphatic filariasis (LF) and National Health Policy has set the goal of LF elimination by 2015. Annual mass drug administration (MDA) is ongoing in endemic districts since 1996-97. Compliance rate is a crucial factor in achieving elimination and was assessed in three districts of Tamil Nadu for 10th and 11th treatment rounds (TRs). An in-depth study assessed the impact of social mobilization by drug distributors (DDs) in two areas from each of the three districts. Overall coverage and compliance for assessed TRs were 76.3 and 67.7% which is below the optimum level to achieve LF elimination. Modifiable determinants continue to be the reason for non-consumption even in the 11th TR and 20.8% were systematic non-compliers. In 76.4% of the cases, DDs failed to adhere to three mandatory visits as per the guidelines. Number of visits by DDs in relation to low and high MDA coverage areas showed a significant relationship (P ≤ 0.000). MDA is limited to drug distribution alone and efforts by DDs in preparing the community were inadequate. Probable means to meet the challenges in preparation of the community is discussed.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23503571</PMID><DateCreated><Year>2013</Year><Month>07</Month><Day>12</Day></DateCreated><DateCompleted><Year>2014</Year><Month>03</Month><Day>26</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1465-3648</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>4</Issue><PubDate><Year>2013</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Health education research</Title><ISOAbbreviation>Health Educ Res</ISOAbbreviation></Journal><ArticleTitle>Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.</ArticleTitle><Pagination><MedlinePgn>591-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/her/cyt042</ELocationID><Abstract><AbstractText>India is a signatory to World Health Assembly resolution for elimination of lymphatic filariasis (LF) and National Health Policy has set the goal of LF elimination by 2015. Annual mass drug administration (MDA) is ongoing in endemic districts since 1996-97. Compliance rate is a crucial factor in achieving elimination and was assessed in three districts of Tamil Nadu for 10th and 11th treatment rounds (TRs). An in-depth study assessed the impact of social mobilization by drug distributors (DDs) in two areas from each of the three districts. Overall coverage and compliance for assessed TRs were 76.3 and 67.7% which is below the optimum level to achieve LF elimination. Modifiable determinants continue to be the reason for non-consumption even in the 11th TR and 20.8% were systematic non-compliers. In 76.4% of the cases, DDs failed to adhere to three mandatory visits as per the guidelines. Number of visits by DDs in relation to low and high MDA coverage areas showed a significant relationship (P ≤ 0.000). MDA is limited to drug distribution alone and efforts by DDs in preparing the community were inadequate. Probable means to meet the challenges in preparation of the community is discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nandha</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Vector Control Research Centre (Indian Council of Medical Research), Medical Complex, Indira Nagar Pondicherry 605 006, India. nandabasker@gmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krishnamoorthy</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Jambulingam</LastName><ForeName>P</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Health Educ Res</MedlineTA><NlmUniqueID>8608459</NlmUniqueID><ISSNLinking>0268-1153</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005369">Filaricides</NameOfSubstance></Chemical><Chemical><RegistryNumber>70288-86-7</RegistryNumber><NameOfSubstance UI="D007559">Ivermectin</NameOfSubstance></Chemical><Chemical><RegistryNumber>F4216019LN</RegistryNumber><NameOfSubstance UI="D015766">Albendazole</NameOfSubstance></Chemical><Chemical><RegistryNumber>V867Q8X3ZD</RegistryNumber><NameOfSubstance UI="D004049">Diethylcarbamazine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>T</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015766" MajorTopicYN="N">Albendazole</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000600" MajorTopicYN="N">supply & distribution</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003153" MajorTopicYN="N">Community Health Services</DescriptorName><QualifierName UI="Q000364" MajorTopicYN="N">manpower</QualifierName><QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003150" MajorTopicYN="N">Community Health Workers</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization & administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003256" MajorTopicYN="N">Community Participation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004049" MajorTopicYN="N">Diethylcarbamazine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060740" MajorTopicYN="N">Disease Eradication</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019353" MajorTopicYN="N">Endemic Diseases</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005369" MajorTopicYN="N">Filaricides</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000600" MajorTopicYN="N">supply & distribution</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006291" MajorTopicYN="N">Health Policy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006792" MajorTopicYN="N">House Calls</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007194" MajorTopicYN="N">India</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007559" MajorTopicYN="N">Ivermectin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000600" MajorTopicYN="N">supply & distribution</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055118" MajorTopicYN="N">Medication Adherence</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008842" MajorTopicYN="N">Microfilariae</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth & development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009313" MajorTopicYN="N">National Health Programs</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization & administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011314" MajorTopicYN="N">Preventive Health Services</DescriptorName><QualifierName UI="Q000364" MajorTopicYN="N">manpower</QualifierName><QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23503571</ArticleId><ArticleId IdType="pii">cyt042</ArticleId><ArticleId IdType="doi">10.1093/her/cyt042</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Inde</li></country></list><tree><noCountry><name sortKey="Jambulingam, P" sort="Jambulingam, P" uniqKey="Jambulingam P" first="P" last="Jambulingam">P. Jambulingam</name><name sortKey="Krishnamoorthy, K" sort="Krishnamoorthy, K" uniqKey="Krishnamoorthy K" first="K" last="Krishnamoorthy">K. Krishnamoorthy</name></noCountry><country name="Inde"><noRegion><name sortKey="Nandha, B" sort="Nandha, B" uniqKey="Nandha B" first="B" last="Nandha">B. Nandha</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001812 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001812 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:23503571
|texte= Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:23503571" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |